Thrivent Financial for Lutherans’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-171,115
| Closed | -$2.63M | – | 2499 |
|
|
2023
Q2 | $2.63M | Sell |
171,115
-92,384
| -35% | -$1.42M | 0.01% | 1172 |
|
|
2023
Q1 | $5.93M | Buy |
263,499
+95,562
| +57% | +$2.15M | 0.01% | 756 |
|
|
2022
Q4 | $3.53M | Buy |
167,937
+2,403
| +1% | +$50.5K | 0.01% | 926 |
|
|
2022
Q3 | $4.08M | Buy |
165,534
+9,960
| +6% | +$245K | 0.01% | 858 |
|
|
2022
Q2 | $3.77M | Sell |
155,574
-27,679
| -15% | -$671K | 0.01% | 916 |
|
|
2022
Q1 | $4.72M | Sell |
183,253
-187
| -0.1% | -$4.82K | 0.01% | 912 |
|
|
2021
Q4 | $5.69M | Sell |
183,440
-79,352
| -30% | -$2.46M | 0.01% | 848 |
|
|
2021
Q3 | $6.37M | Buy |
+262,792
| New | +$6.37M | 0.01% | 813 |
|
|
2021
Q2 | – | Sell |
-247,011
| Closed | -$6.17M | – | 2557 |
|
|
2021
Q1 | $6.17M | Buy |
247,011
+82,628
| +50% | +$2.06M | 0.01% | 837 |
|
|
2020
Q4 | $4.48M | Buy |
164,383
+105,861
| +181% | +$2.89M | 0.01% | 904 |
|
|
2020
Q3 | $1.08M | Buy |
+58,522
| New | +$1.08M | ﹤0.01% | 1527 |
|